Skip to main content
Caplight Logo









AMPEL BioSolutions

AMPEL BioSolutions

Private
Charlottesville, VirginiaHealthcare & Life Scienceshttps://ampelbiosolutions.com/

Last Round

Grant

May 18, 2023

Total Funding Raised

$800,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AMPEL BioSolutions is a biotechnology company that develops clinical genomic tests and precision medicine solutions for autoimmune and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

precision medicinegene expression testingclinical decision supportgenomic analyticsbiomarker discoveryautoimmune disease diagnosticsclinical trial patient selectionRNA sequencingAI diagnosticsdrug developmentCLIA-certified laboratorydigital biomarkerscompanion diagnosticsAI in healthcaregenomic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMPEL BioSolutions Comparables

Compare AMPEL BioSolutions with similar companies based on industry and business-model similarity.

AMPEL BioSolutions comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Progentec Diagnostics
88%
DxTerity Diagnostics
87%
Scipher Medicine
82%

AMPEL BioSolutions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 18, 2023
Series AJan 17, 2020

Key People

Founding team and executive leadership

Peter Lipsky

Chief Executive Officer

Executive Team

Neil Lyons

Chief Financial Officer

Executive Team

AMPEL BioSolutions Investors

Notable investors and investment history

AMPEL BioSolutions investors
InvestorRounds
Virginia CatalystGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 38% MoM, from 2.5K to 3.5K.

  • May 16, 2026

    Monthly visitors increased 95% MoM, from 1.7K to 3.3K.

AMPEL BioSolutions Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AMPEL BioSolutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AMPEL BioSolutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersCharlottesville, Virginia
Employee Range12
Year Founded2013
Last FundingMay 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?